RT Journal Article
SR Electronic
T1 Fundamental Bound on Epidemic Overshoot in the SIR Model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.02.23290891
DO 10.1101/2023.06.02.23290891
A1 Nguyen, Maximilian M.
A1 Freedman, Ari S.
A1 Ozbay, Sinan A.
A1 Levin, Simon A.
YR 2023
UL http://medrxiv.org/content/early/2023/06/06/2023.06.02.23290891.abstract
AB We derive an exact upper bound on the epidemic overshoot for the Kermack-McKendrick SIR model. This maximal overshoot value of 0.2984… occurs at . Using the general analysis framework presented within, we then consider more complex SIR models, such as those that incorporate vaccination or contact heterogeneity. We analyze models that consider vaccinations and show that the presence of vaccinated individuals decreases the maximum possible overshoot. For epidemics where the contact structure is given by a network, we numerically find that increased contact heterogeneity lowers the maximal overshoot value and weakens the dependency of overshoot on transmission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the National Science Foundation (CCF1917819 and CNS-2041952), the Army Research Office (W911NF-18-1-0325), and a gift from the William H. Miller III 2018 Trust.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript.